Xao X. Tang

发表

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas

E. Rappaport, H. Shimada, N. Ikegaki, 2013, Proceedings of the National Academy of Sciences.

Biological significance of EPHA2 expression in neuroblastoma.

N. Ikegaki, Huaqing Zhao, B. Kung, 2009, International journal of oncology.

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

H. Shimada, N. Ikegaki, Xao X. Tang, 2022, Genes & Immunity.

S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines

E. Rappaport, N. Ikegaki, S. Hicks, 2013, International journal of oncology.

Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma

M. E. Robinson, N. Ikegaki, A. Flake, 2004, Clinical Cancer Research.

Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.

E. Rappaport, N. Ikegaki, Paul L. Regan, 2010, International Journal of Oncology.

Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma.

Gerald Wang, Paul L. Regan, Joshua Jacobs, 2010, International journal of oncology.

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma

H. Shimada, N. Ikegaki, Xao X. Tang, 2021, Frontiers in Immunology.

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin

N. Ikegaki, Sarah Lomahan, T. Tran, 2013, International journal of molecular medicine.

The MYCN enigma: significance of MYCN expression in neuroblastoma.

N. Cheung, R. Seeger, N. Ikegaki, 2006, Cancer research.

Clinical Implications of Neuroblastoma Stem Cells

H. Shimada, Xao X. Tang, Xao X. Tang, 2013 .

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

A. Look, A. Naranjo, J. Gastier-Foster, 2013, Cancer.

Biological significance of EPHA 2 expression in neuroblastoma

N. Ikegaki, Huaqing Zhao, B. Kung, 2022 .

De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene

E. Rappaport, R. Seeger, N. Ikegaki, 2007, Clinical Cancer Research.

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group

A. Look, A. Naranjo, J. Gastier-Foster, 2017, Oncotarget.

A variant transcript encoding an isoform of the human protein tyrosine kinase EPHB2 is generated by alternative splicing and alternative use of polyadenylation signals

D. Pleasure, N. Ikegaki, G. Brodeur, 1998, Oncogene.

High-Level Expression of EPHB 6 , EFNB 2 , and EFNB 3 Is Associated with Low Tumor Stage and High TrkA Expression in Human Neuroblastomas 1

A. Cnaan, W. London, N. Ikegaki, 1999 .